| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 20.232 | 26.186 | 24.598 | 28.432 | 34.022 | 39.441 | 53.320 | 53.749 | 80.823 | 109.660 |
| Total Income - EUR | 20.316 | 26.219 | 24.612 | 28.500 | 34.056 | 39.476 | 72.813 | 54.473 | 82.968 | 112.639 |
| Total Expenses - EUR | 14.348 | 20.005 | 18.943 | 18.309 | 20.591 | 22.008 | 37.301 | 43.814 | 40.342 | 54.280 |
| Gross Profit/Loss - EUR | 5.968 | 6.214 | 5.670 | 10.191 | 13.465 | 17.468 | 35.512 | 10.659 | 42.626 | 58.360 |
| Net Profit/Loss - EUR | 5.228 | 5.902 | 5.283 | 9.907 | 13.130 | 16.882 | 34.527 | 10.126 | 42.011 | 55.386 |
| Employees | 0 | 2 | 2 | 1 | 1 | 0 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Sanovita Nico Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.888 | 11.063 | 10.810 | 34.733 | 30.595 | 25.478 | 12.017 | 12.223 | 6.973 | 3.416 |
| Current Assets | 31.017 | 30.208 | 31.399 | 33.393 | 46.852 | 53.861 | 77.587 | 84.895 | 120.832 | 146.485 |
| Inventories | 6.876 | 5.662 | 6.527 | 6.969 | 7.166 | 6.652 | 7.016 | 0 | 0 | 0 |
| Receivables | 10.279 | 9.300 | 9.434 | 7.877 | 9.749 | 11.866 | 12.831 | 7.627 | 4.208 | 4.286 |
| Cash | 13.863 | 15.246 | 15.438 | 18.546 | 29.938 | 35.342 | 57.740 | 77.268 | 116.624 | 142.199 |
| Shareholders Funds | 5.273 | 5.947 | 5.327 | 9.950 | 13.173 | 16.923 | 66.395 | 10.174 | 50.121 | 105.227 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 27.632 | 35.324 | 36.882 | 58.176 | 64.274 | 62.415 | 23.230 | 87.095 | 77.801 | 44.876 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sanovita Nico Med Srl